Best-case | High efficacy | Real-life | |
---|---|---|---|
G6PD deficiency | 4.6% | 4.6% | 4.6% |
CYP2D6 slow metabolizers | 3.4% | 3.4% | 3.4% |
Pregnancy | 7.5% | 7.5% | 7.5% |
Coverage | |||
Case-management | 100% | 80% | 80% |
Intervention | 80% | 80% | 80% |
Bloodstage drug | |||
Efficacy (alone) | 100% | 100% | 89.9% |
Efficacy (with anti-hpz) | 100% | 100% | 94.6% |
Prophylaxis duration | 28 days | 28 days | 14 days |
Hypnozoiticidal drug | |||
Efficacy | 100% | 80% | 71.36% |
Prophylaxis duration | 28 days | 8 days | 8 days |
Adherence | 100% | 80% | 66.7% |
Minimum age | 0 days | 180 days | 180 days |
Pregnancy | administer | don't administer | don't administer |
G6PD deficiency | administer | don't administer | don't administer |
CYP2D6 slow metabolizers | effective | not effective | not effective |